Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00000243 · ClinicalTrials.gov registry record · NA
Effects of Buprenorphine/Naloxone in Treating Opioid Dependent Individuals Who Are Maintained on Methadone
A NA study, sponsored by National Institute on Drug Abuse (NIDA).
- Terminated
- Registry status
- NA
- Development phase
- 16
- Enrollment target
NCT00000243 is a NA study that was terminated before completion, run by National Institute on Drug Abuse (NIDA). The registered enrollment target is 16 participants.
The verdict
NCT00000243, a NA study, was terminated before completion, sponsored by National Institute on Drug Abuse (NIDA).
- TERMINATED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
Study Summary
Buprenorphine is a drug that may be helpful in treating opioid dependent individuals who were previously maintained on methadone. The purpose of this study is to determine the effects of different doses of buprenorphine/naloxone in treating opioid dependent individuals who were previously maintained on methadone.
Interventions
- DRUG Buprenorphine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2002-09 |
| Est. Completion | 2004-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00000243
The ClinicalTrials.gov registry entry for NCT00000243 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute on Drug Abuse (NIDA), which has 335 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Buprenorphine is the first listed.
NCT00000243 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00000243 about?
NCT00000243 is a clinical study titled "Effects of Buprenorphine/Naloxone in Treating Opioid Dependent Individuals Who Are Maintained on Methadone". Buprenorphine is a drug that may be helpful in treating opioid dependent individuals who were previously maintained on methadone. The purpose of this study is to determine the effects of different doses of buprenorphine/naloxone in treating opioid dependent individuals who were previously maintained...
What is the current status of trial NCT00000243?
This trial is currently terminated. It is a NA study. The enrollment target is 16 participants. The study started on 2002-09. Estimated completion is 2004-01.
What interventions are being tested in trial NCT00000243?
The interventions under investigation include: Buprenorphine (DRUG).
Who is sponsoring clinical trial NCT00000243?
This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.